Loading...
•
Sep 30, 2025
GE HealthCare Q3 2025 Earnings Report
GE HealthCare delivered solid Q3 2025 results, with 6% revenue growth and higher adjusted EPS, supported by strong performance in Imaging and PDx.
Key Takeaways
GE HealthCare posted a strong third quarter, driven by 6% organic revenue growth, improved adjusted EBIT margin, and continued strategic investments in innovation and productivity.
Revenue reached $5.14B, up 6% organically year-over-year.
GAAP EPS was $0.98; Adjusted EPS was $1.07, up 4% year-over-year.
Imaging and Pharmaceutical Diagnostics drove performance, each growing 9%.
Raised the lower end of full-year adjusted EPS guidance to $4.25–$4.35.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
GE HealthCare raised the lower end of its full-year adjusted EPS outlook to $4.25–$4.35 and reaffirmed revenue and margin expectations.
Positive Outlook
- Increased lower end of adjusted EPS guidance to $4.25.
- Reaffirmed 4–6% organic revenue growth outlook for FY25.
- Reaffirmed adjusted EBIT margin guidance of 15.3–15.7%.
- Strength in Imaging and PDx continues into Q4.
- Ongoing productivity and price realization expected to support margins.
Challenges Ahead
- PCS revenue slightly declined YoY in the quarter.
- Continued FX headwinds expected into Q4.
- Productivity gains partially offset by inflationary pressure.
- Modest growth expected in Europe and Latin America.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...